Skip to content
Screener

BillionToOne, Inc. BLLN Q3 2025 earnings

Reported December 9, 2025 · After market close

Revenue$83.5MBeat by $623.3K
EPS$0.10Miss by $0.04
Revenue estimate$82.9M
EPS estimate$0.14

Next report

Oct 6, 2026 (In 3 days)
Revenue estimate$115.8M
EPS estimate$0.16

Financials

Q3 2025

Income statement

See full
Revenue$83.5M+117%
Gross profit$58.4M+189%
Operating income$9.6M+176%
Net income$5.7M+138%
EPS (diluted)$0.10+107%

Balance sheet

See full
Cash & equivalents$195.2M-3.5%
Total debt$108.1M—
Total equity-$239.5M+1.4%
Total assets$327.5M—

Cash flow

See full
Operating cash flow$10.0M—
CapEx$2.1M—
Free cash flow$7.9M—

Valuation & ratios

Profitability

See full
Gross margin65.2%—
Operating margin-2.4%—
Net margin-3.9%—
FCF margin-1.6%—

Returns & leverage

See full
Current ratio6.2×—

Segments

By product

See full
Prenatal$74.1M+102%
Oncology$8.7M+664%
Clinical trial support and other services$761.0K+11.9%

FAQ

When did BillionToOne, Inc. report Q3 2025 earnings?
BillionToOne, Inc. (BLLN) reported Q3 2025 earnings on December 9, 2025 after market close.
What were BillionToOne, Inc.'s Q3 2025 revenue and EPS?
BillionToOne, Inc. reported revenue of $83.5M and eps of $0.10 for Q3 2025.
Did BillionToOne, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $82.9M by $623.3K. EPS missed the consensus estimate of $0.14 by $0.04.
Where can I find BillionToOne, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-056077) and the 10-Q periodic report (0001628280-25-056321) directly on SEC EDGAR. The filing index links above go to sec.gov.